{"id":15756,"date":"2020-07-15T13:55:59","date_gmt":"2020-07-15T08:55:59","guid":{"rendered":"https:\/\/www.vosa.tv\/?p=15756"},"modified":"2020-07-15T13:55:59","modified_gmt":"2020-07-15T08:55:59","slug":"covid-19-vaccine-tested-on-humans-shows-early-promise","status":"publish","type":"post","link":"https:\/\/www.vosa.tv\/eng\/archives\/15756","title":{"rendered":"COVID-19 vaccine tested on humans shows early promise"},"content":{"rendered":"<p><strong>BOGOTA, Colombia<\/strong><\/p>\n<p>A Massachusetts-based biotech company has been testing a possible vaccine against the novel corona virus which is showing early signs of success.<\/p>\n<p>Moderna Therapeutics announced an estimated start date for phase 3 trials, its final phase of testing.<\/p>\n<p>The trial involved 45 volunteers aged 18 to 55 who received one of three dosage levels of the vaccine, which was given in two injections about a month apart.<\/p>\n<p>Researchers measured virus-recognizing antibodies in all participants and detected levels similar to or higher than those found in the blood of people who have recovered from COVID-19.<\/p>\n<p>It is not clear how long the immune response will protect against COVID-19, but volunteers will be monitored for a year to find out. Some participants experienced mild side effects such as fatigue, chills, headache and weakness.<\/p>\n<p>Moderna\u2019s vaccine, which is being co-developed with the US National Institute of Allergy and Infectious Diseases (NIAID), began safety testing in humans in March. Phase 3 tests will begin on July 27 and will involve 30,000 people, according to a May 18 press release.<\/p>\n<p>Half of the participants will be a control group who will receive placebos. This large clinical trial is expected to be completed by late October.<\/p>\n<p>More than 100 vaccines worldwide are being studied for use against COVID-19, and at least eight of these have already progressed to human studies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BOGOTA, Colombia A Massachusetts-based biotech company has been testing a possible vaccine against the novel corona virus which is showing early signs of success. Moderna Therapeutics announced an estimated start date for phase 3 trials, its final phase of testing. The trial involved 45 volunteers aged 18 to 55 who received one of three dosage [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":13992,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[],"class_list":["post-15756","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/15756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/comments?post=15756"}],"version-history":[{"count":1,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/15756\/revisions"}],"predecessor-version":[{"id":15757,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/posts\/15756\/revisions\/15757"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media\/13992"}],"wp:attachment":[{"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/media?parent=15756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/categories?post=15756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vosa.tv\/eng\/wp-json\/wp\/v2\/tags?post=15756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}